blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1937213

EP1937213 - SYSTEMS AND METHODS FOR MANUFACTURING LIPOSOMES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.08.2018
Database last updated on 17.05.2024
FormerThe patent has been granted
Status updated on  22.09.2017
FormerGrant of patent is intended
Status updated on  16.05.2017
Most recent event   Tooltip05.06.2020Lapse of the patent in a contracting state
New state(s): HU, PT		published on 08.07.2020  [2020/28]
Applicant(s)For all designated states
Protiva Biotherapeutics Inc.
100-8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8 / CA
[2011/01]
Former [2008/27]For all designated states
Protiva Biotherapeutics Inc.
100-3480 Gilmore Way Burnaby
British Columbia V5G 4Y1 / CA
Inventor(s)01 / MACLACHLAN, Ian
8040 Aves Terrace
Mission, British Columbia V4S 1E5 / CA
02 / JEFFS, Lloyd B.
5218 Walnut Place
Delta, British Columbia V4K 3B4 / CA
03 / YAWORSKI, Edward
23106 - 123b Avenue
Maple Ridge, British Columbia V2X 9Z7 / CA
04 / LAM, Kieu
18871 71 Avenue
Surrey, British Columbia V4N 5M7 / CA
 [2008/27]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2017/43]J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2009/37]Campbell, Patrick John Henry
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Former [2008/27]Campbell, Patrick John Henry
J.A. Kemp & Co. 14 South Square Gray's Inn
GB-London WC1R 5JJ / GB
Application number, filing date06761194.727.07.2006
[2008/27]
WO2006CA01239
Priority number, dateUS20050703380P27.07.2005         Original published format: US 703380 P
[2008/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007012191
Date:01.02.2007
Language:EN
[2007/05]
Type: A1 Application with search report 
No.:EP1937213
Date:02.07.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 01.02.2007 takes the place of the publication of the European patent application.
[2008/27]
Type: B1 Patent specification 
No.:EP1937213
Date:25.10.2017
Language:EN
[2017/43]
Search report(s)International search report - published on:CA01.02.2007
(Supplementary) European search report - dispatched on:EP04.08.2011
ClassificationIPC:A61K9/127, A61K31/7088, A61K38/00, A61K38/43, A61K39/00, A61K47/44, A61K48/00
[2008/27]
CPC:
A61K9/127 (EP,US); A61K31/7088 (EP,US); A61K48/00 (EP,US);
A61K48/0025 (EP,US); A61K9/1277 (EP,US); A61P35/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/43]
Former [2008/27]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL25.02.2008
BA25.02.2008
HR25.02.2008
MK25.02.2008
RS25.02.2008
TitleGerman:SYSTEME UND VERFAHREN ZUR HERSTELLUNG VON LIPOSOMEN[2008/27]
English:SYSTEMS AND METHODS FOR MANUFACTURING LIPOSOMES[2008/27]
French:SYSTEMES ET PROCEDES DE FABRICATION DE LIPOSOMES[2008/27]
Entry into regional phase25.02.2008National basic fee paid 
25.02.2008Search fee paid 
25.02.2008Designation fee(s) paid 
25.02.2008Examination fee paid 
Examination procedure25.02.2008Examination requested  [2008/27]
29.02.2012Amendment by applicant (claims and/or description)
03.08.2015Despatch of a communication from the examining division (Time limit: M04)
20.11.2015Reply to a communication from the examining division
17.05.2017Communication of intention to grant the patent
12.09.2017Fee for grant paid
12.09.2017Fee for publishing/printing paid
12.09.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.08.2015
Opposition(s)26.07.2018No opposition filed within time limit [2018/40]
Fees paidRenewal fee
10.07.2008Renewal fee patent year 03
08.07.2009Renewal fee patent year 04
08.07.2010Renewal fee patent year 05
12.07.2011Renewal fee patent year 06
13.07.2012Renewal fee patent year 07
10.07.2013Renewal fee patent year 08
14.07.2014Renewal fee patent year 09
10.07.2015Renewal fee patent year 10
11.07.2016Renewal fee patent year 11
12.07.2017Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.07.2006
AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
IT25.10.2017
LT25.10.2017
LV25.10.2017
MC25.10.2017
NL25.10.2017
PL25.10.2017
PT25.10.2017
RO25.10.2017
SI25.10.2017
SK25.10.2017
TR25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
[2020/27]
Former [2020/16]AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
IT25.10.2017
LT25.10.2017
LV25.10.2017
MC25.10.2017
NL25.10.2017
PL25.10.2017
RO25.10.2017
SI25.10.2017
SK25.10.2017
TR25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2019/15]AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
IT25.10.2017
LT25.10.2017
LV25.10.2017
MC25.10.2017
NL25.10.2017
PL25.10.2017
RO25.10.2017
SI25.10.2017
SK25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2018/52]AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
IT25.10.2017
LT25.10.2017
LV25.10.2017
NL25.10.2017
PL25.10.2017
RO25.10.2017
SI25.10.2017
SK25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2018/41]AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
IT25.10.2017
LT25.10.2017
LV25.10.2017
NL25.10.2017
PL25.10.2017
RO25.10.2017
SK25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2018/39]AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
IT25.10.2017
LT25.10.2017
LV25.10.2017
NL25.10.2017
PL25.10.2017
SK25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2018/37]AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
LT25.10.2017
LV25.10.2017
NL25.10.2017
PL25.10.2017
SK25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2018/35]AT25.10.2017
CY25.10.2017
CZ25.10.2017
DK25.10.2017
EE25.10.2017
ES25.10.2017
FI25.10.2017
LT25.10.2017
LV25.10.2017
NL25.10.2017
SK25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2018/24]AT25.10.2017
ES25.10.2017
FI25.10.2017
LT25.10.2017
LV25.10.2017
NL25.10.2017
BG25.01.2018
GR26.01.2018
IS25.02.2018
Former [2018/23]AT25.10.2017
ES25.10.2017
FI25.10.2017
LT25.10.2017
NL25.10.2017
GR26.01.2018
IS25.02.2018
Former [2018/22]ES25.10.2017
FI25.10.2017
LT25.10.2017
NL25.10.2017
Former [2018/17]NL25.10.2017
Documents cited:Search[A]US5653996  (HSU CHUNG C [US]) [A] 1-30* the whole document *;
 [Y]EP1203614  (POLYMUN SCIENT IMMUNBIO FORSCH [AT]) [Y] 1-30 * the whole document *;
 [XY]WO2004002453  (PROTIVA BIOTHERAPEUTICS LTD [CA], et al) [X] 1-30 * the whole document * [Y] 1-30
International search[X]CA2491164  (PROTIVA BIOTHERAPEUTICS LTD [CA]);
 [X]CA2427640  (POLYMUN SCIENT IMMUNBIO FORSCH [AT]);
 [Y]WO0105373  (INEX PHARMACEUTICALS CORP [CA], et al);
 [Y]WO8907929  (MICRO PAK INC [US]);
 [A]WO0029103  (OPTIME THERAPEUTICS INC [US])
 [X]  - JEFFS ET AL., "A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA", PHARMACEUTICAL RESEARCH, (2005), vol. 22, no. 3, pages 362 - 372, XP019370801

DOI:   http://dx.doi.org/10.1007/s11095-004-1873-z
 [Y]  - WAGNER ET AL., "The crossflow injection technique: An improvement of the ethanol injection method", JOURNAL OF LIPOSOME RESEARCH, (2002), vol. 12, no. 3, pages 259 - 270, XP001133467

DOI:   http://dx.doi.org/10.1081/LPR-120014761
by applicantUS5478860
 WO0105373
 US2004142025
 WO2004002453
 WO2005000373
 WO2005026372
 US2003077829
 US2005008689
 US5885613
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.